🔗 Permalink

Inventor profile of:

Thomas Egebjerg

City:

Ganloese

Country:

Denmark

Published Applications:

Last publication date:

2026-02-05

Top Assignees for applications by Thomas Egebjerg

The entities that hold a legal rights for patent applications filed by inventor Egebjerg Thomas:

Novo Nordisk A/S 6 Bagsvaerd, Denmark

Recent patent applications by Egebjerg Thomas

Thomas Egebjerg from Ganloese, DK has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-02-05

US20260035450A1

Chemistry; metallurgy

NOVEL ANTI-ANGPTL3 ANTIBODIES SUITABLE FOR HIGH CONCENTRATION COMPOSITIONS AND SUBCUTANEOUS ADMINISTRATION

#2 | 2025-10-30

US20250333496A1

Chemistry; metallurgy

ANTI IL-6 DOMAIN ANTIBODIES WITH FATTY ACID SUBSTITUENTS

#3 | 2025-03-27

US20250101094A1

Chemistry; metallurgy

ANTI IL-6 DOMAIN ANTIBODIES

#4 | 2024-12-26

US20240425837A1

Chemistry; metallurgy

HIGHLY POTENT ISVD COMPOUNDS CAPABLE OF SUBSTITUTING FOR FVIII(A)

#5 | 2024-02-29

US20240067944A1

Chemistry; metallurgy

Highly potent ISVD compounds capable of substituting for FVIII(A)

#6 | 2024-02-08

US20240043516A1

Chemistry; metallurgy

NOVEL ANTI-ANGPTL3 ANTIBODIES SUITABLE FOR HIGH CONCENTRATION COMPOSITIONS AND SUBCUTANEOUS ADMINISTRATION

#7 | 2023-11-02

US20230348582A1

Chemistry; metallurgy

Anti-ANGPTL3 antibodies suitable for high concentration compositions and subcutaneous administration

#8 | 2019-02-28

US20190062429A1

Chemistry; metallurgy

Targeting tissue factor to activated platelets

#9 | 2016-09-22

US20160272710A1

Chemistry; metallurgy

Targeting tissue factor to activated platelets

#10 | 2013-02-28

US20130052192A1

Chemistry; metallurgy

Activatable Constructs

#11 | 2012-07-12

US20120178908A1

Chemistry; metallurgy

TARGETING TISSUE FACTOR TO ACTIVATED PLATELETS

InventorID:

113574 ⎘